Whitehawk Therapeutics (WHWK) Minority Interest (2015 - 2016)
Whitehawk Therapeutics' (WHWK) quarterly Minority Interest came in at $73.8 million in Q4 2016, up 4.64% year-on-year from $70.5 million in Q1 2016, and up 4.64% on a QoQ basis from $70.5 million in Q4 2015.
Whitehawk Therapeutics (WHWK) Minority Interest (2015 - 2016) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 2 years of Minority Interest data on file, last reported at $73.8 million in Q4 2016.
- On a quarterly basis, Minority Interest rose 4.64% year-over-year to $73.8 million in Q4 2016; TTM through Dec 2016 was $73.8 million, a 4.64% increase from a year earlier, with the FY2016 full-year figure at $73.8 million, up 4.64% from the prior year.
- Minority Interest for Q4 2016 stood at $73.8 million, up from $70.5 million in the prior quarter.
- Over the last five years, Minority Interest for WHWK reached as high as $73.8 million in Q4 2016 and fell as low as $70.5 million in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Whitehawk Therapeutics | 256.87 Mn | 45.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 73.76 Mn |
| Dec 31, 2015 | 70.49 Mn |